Pharmaceutical Fronts (Jun 2022)

Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

  • Yan-Qi Zhao,
  • Li-Jun Li,
  • Er-Fen Zhou,
  • Jiang-Yue Wang,
  • Ying Wang,
  • Lin-Miao Guo,
  • Xin-Xin Zhang

DOI
https://doi.org/10.1055/s-0042-1751036
Journal volume & issue
Vol. 04, no. 02
pp. e43 – e60

Abstract

Read online

Abstract Lipid-based nanocarriers have been extensively investigated for drug delivery due to their advantages including biodegradability, biocompatibility, nontoxicity, and nonimmunogenicity. However, the shortcomings of traditional lipid-based nanocarriers such as insufficient targeting, capture by the reticuloendothelial system, and fast elimination limit the efficiency of drug delivery and therapeutic efficacy. Therefore, a series of multifunctional lipid-based nanocarriers have been developed to enhance the accumulation of drugs in the lesion site, aiming for improved diagnosis and treatment of various diseases. In this review, we summarized the advances and applications of lipid-based nanocarriers from traditional to novel functional lipid preparations, including liposomes, stimuli-responsive lipid-based nanocarriers, ionizable lipid nanoparticles, lipid hybrid nanocarriers, as well as biomembrane-camouflaged nanoparticles, and further discussed the challenges and prospects of this system. This exploration may give a complete idea viewing the lipid-based nanocarriers as a promising choice for drug delivery system, and fuel the advancement of pharmaceutical products by materials innovation and nanotechnology.

Keywords